Showing results (341-350 of 411) with videos related to
Sort By:
Pageof 42
Cancer Discovery|May 14, 2024
Perivascular NOTCH3+ Stem Cells Drive Meningioma Tumorigenesis and Resistance to RadiotherapyAbrar Choudhury, Martha A Cady, Calixto-Hope G Lucas, et al.Journal of the National Cancer Institute|January 26, 2011
Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association studyOlivia Fletcher, Nichola Johnson, Nick Orr, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2013
Efficacy of chemotherapy in BRCA1/2 mutation carrier ovarian cancer in the setting of PARP inhibitor resistance: a multi-institutional studyJoo Ern Ang, Charlie Gourley, C Bethan Powell, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2009
PPM1D is a potential therapeutic target in ovarian clear cell carcinomasDavid S P Tan, Maryou B K Lambros, Sydonia Rayter, et al.Biorxiv : the Preprint Server for Biology|May 25, 2026
Toward a Random Background for Ligand OptimizationXinyu Xu, Olivier Mailhot, Galen J Correy, et al.Science (New York, N.Y.)|September 30, 2021
A protein interaction landscape of breast cancerMinkyu Kim, Jisoo Park, Mehdi Bouhaddou, et al.Biorxiv : the Preprint Server for Biology|August 16, 2024
The Mac1 ADP-ribosylhydrolase is a Therapeutic Target for SARS-CoV-2Rahul K Suryawanshi, Priyadarshini Jaishankar, Galen J Correy, et al.Delirium (Bielefeld, Germany)|February 13, 2024
The Delphi Delirium Management Algorithms. A practical tool for clinicians, the result of a modified Delphi expert consensus approachThomas H Ottens, Carsten Hermes, Valerie Page, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2019
DNA-Dependent Protein Kinase Drives Prostate Cancer Progression through Transcriptional Regulation of the Wnt Signaling PathwayVishal Kothari, Jonathan F Goodwin, Shuang G Zhao, et al.Cancer Discovery|April 4, 2018
E-Cadherin/ROS1 Inhibitor Synthetic Lethality in Breast CancerIlirjana Bajrami, Rebecca Marlow, Marieke van de Ven, et al.Pageof 42